Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aladdin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|April 16, 1998
[Virus simulates killer cells]B K Pedersen, H Aladdin, H Ullum
Scandinavian Journal of Immunology|May 3, 2000
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, H Ullum, T Katzenstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Immune function and phenotype before and after highly active antiretroviral therapyS R Søndergaard, H Aladdin, H Ullum, et al.
Scandinavian Journal of Immunology|September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, M Von Essen, P Schjerling, et al.
Annals of Internal Medicine|July 6, 2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxisT L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Immunology|May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatmentH Ullum, T Katzenstein, H Aladdin, et al.
Ugeskrift for Laeger|May 22, 2001
[No development of HIV infection after transfusion with HIV-contaminated blood and postexposure antiviral prevention]T L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Immunology|May 20, 2003
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppressionH Aladdin, T Katzenstein, A-M Dreves, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|April 16, 1998
[Virus simulates killer cells]B K Pedersen, H Aladdin, H Ullum
Scandinavian Journal of Immunology|May 3, 2000
Immunological and virological changes in antiretroviral naïve human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, H Ullum, T Katzenstein, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Immune function and phenotype before and after highly active antiretroviral therapyS R Søndergaard, H Aladdin, H Ullum, et al.
Scandinavian Journal of Immunology|September 14, 2001
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAARTH Aladdin, M Von Essen, P Schjerling, et al.
Annals of Internal Medicine|July 6, 2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxisT L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Immunology|May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatmentH Ullum, T Katzenstein, H Aladdin, et al.
Ugeskrift for Laeger|May 22, 2001
[No development of HIV infection after transfusion with HIV-contaminated blood and postexposure antiviral prevention]T L Katzenstein, E Dickmeiss, H Aladdin, et al.
Scandinavian Journal of Immunology|May 20, 2003
T-cell receptor excisional circles, telomere length, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppressionH Aladdin, T Katzenstein, A-M Dreves, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
Scandinavian Journal of Immunology|March 18, 2000
Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patientsH Aladdin, C S Larsen, B K Møller, et al.
Pageof 2